Toshihiko Ohtomo

This inventor holds 26 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Cancer Therapeutics. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Perseus Proteomics Inc., F. Hoffmann-La Roche Ag. Active years: 2001-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshihiko Ohtomo. Retrieved from https://idiyas.com/inventor/toshihiko-ohtomo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 3)

% Patents Active = 38.5

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 145(Granted Patents)

Location History:

Gotenba, JP (2001 - 2009)
Nishihari-mura, Nishihari-gun, Ibaraki, JP (2010)
Gotemba, JP (2003 - 2011)
Shizuoka-ken, JP (2013)
Shizuoka, JP (2006 - 2015)
Ibaraki, JP (2016)
Tokyo, JP (2017 - 2023)

Company Filing History:

25 out of 987

Chugai Seiyaku Kabushiki Kaisha

patents

4 out of 27

Perseus Proteomics Inc.

patents

2 out of 181

F. Hoffmann-La Roche Ag

Jsr Life Sciences Corporation

patents

7. 5 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2023

Loading Chart...

Areas of Expertise:

Cancer Treatment

GPC3-targeting Drug

Anti-ROBO1 Antibody

Gene Overexpression

Soluble GPC3 Protein

cDNA Isolation

TGF-β Inhibition

Mannosyltransferase Polypeptides

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11767362 - Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies (2023-09-26),

2. 11760807 - GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy (2023-09-19),

3. 11376326 - GPC3-targeting therapeutic agent which is administered to patient for whom the GPC3-targeting therapeutic agent is effective (2022-07-05),

4. 10782300 - GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy (2020-09-22),

5. 10451627 - Method for assaying soluble GPC3 protein (2019-10-22),

6. 9644029 - Cancer diagnosis and treatment of cancer using anti-ROBO1 antibody (2017-05-09),

7. 9434775 - Gene overexpressed in cancer (2016-09-06),

8. 9376475 - Gene overexpressed in cancer (2016-06-28),

9. 8940488 - Cancer diagnosis and treatment of cancer using anti-robo 1 antibody (2015-01-27),

10. 8586039 - Degraded TPO agonist antibody (2013-11-19),

11. 8105799 - Methods of screening compounds inhibiting signal transduction through inflammatory cytokines (2012-01-31),

12. 8034903 - Degraded TPO agonist antibody (2011-10-11),

13. 7892543 - Reshaped human anti-HM 1.24 antibody (2011-02-22),

14. 7812128 - Gene overexpressed in cancer (2010-10-12),

15. 7666610 - Expressing transporters on viral envelopes (2010-02-23),

Title: The Innovative Journey of Toshihiko Ohtomo

Introduction:

Toshihiko Ohtomo, a pioneering inventor hailing from Shizuoka, Japan, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents:

Ohtomo's latest patents include advancements in renewable energy technologies, specifically in the development of solar panels with increased efficiency and durability. These patents showcase his commitment to sustainability and environmental conservation.

Career Highlights:

Throughout his illustrious career, Ohtomo has been recognized for his innovative spirit and technical expertise. He has received numerous awards for his contributions to the renewable energy sector and has been instrumental in shaping the future of clean energy solutions.

Collaborations:

Ohtomo has collaborated with leading research institutions and universities to further his research and bring his inventions to life. His partnerships with industry experts have led to the successful implementation of his patented technologies in real-world applications.

Conclusion:

In conclusion, Toshihiko Ohtomo stands as a visionary inventor whose dedication to technological advancement and environmental sustainability has left a lasting impact on the industry. His innovative spirit continues to inspire future generations of inventors and researchers in the pursuit of a greener tomorrow.

Profile summary based on public USPTO records.